ID

22692

Description

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Mots-clés

Versions (1)
  1. 09/06/2017 09/06/2017 -
Détendeur de droits

Genentech, Inc.

Téléchargé le

9 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

Anglais

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

1 Formulaires  
Patient administration
Description

Patient administration

Subject Number
Description

PT

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Description

PTINIT

Type de données

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Report Date:
Description

VDT

Type de données

date

Alias
UMLS CUI [1,1]
C1302584
FOLLOW-UP CONTACT (DAY 0)
Description

FOLLOW-UP CONTACT (DAY 0)

Was the subject contacted 2-4 days after study treatment?
Description

CONTACT [CONTAC]

Type de données

boolean

Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C2709088
Date of Contact:
Description

CONTACT_DT [CONDT]

Type de données

date

Unités de mesure
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C0011008
DD/MMM/YY
Has the subject been taking the prescribed self-administered post-injection antimicrobials?
Description

Note: If Yes was answered to any of the questions below, the subject should return as soon as possible to the clinic for a safety assessment. Record on AE or SAE CRF if appropriate.

Type de données

boolean

Alias
UMLS CUI [1]
C0338237
Decrease in Vision: Has the subject experienced a decrease in vision in the study eye since treatment?
Description

VISION_DECREASED [VSNDEC]

Type de données

boolean

Alias
UMLS CUI [1]
C4280600
Eye Pain: Has the subject had any eye pain in the study eye since treatment?
Description

EYE_PAIN [EYEPN]

Type de données

boolean

Alias
UMLS CUI [1]
C0151827
Unusual Redness: Has the subject had any new or unusual redness in the study eye (other than localized redness at the injection site) since treatment?
Description

EYE_REDNESS [EYERED]

Type de données

boolean

Alias
UMLS CUI [1]
C0235267
New Ocular Symptoms: Has the subject experienced any other new ocular symptoms in the study eye since treatment?
Description

NEW_SYMPTOM [NEWSX]

Type de données

boolean

Alias
UMLS CUI [1]
C0586406
Safety Assessment Visit: Was the subject asked to return to the clinic for a safety assessment visit?
Description

ASSESSMENT_DONE [ASMTDN]

Type de données

boolean

Alias
UMLS CUI [1,1]
C0589121
UMLS CUI [1,2]
C0549076
Retour au début de la page

Similar models

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Patient administration
PT
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
PTINIT
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
VDT
Item
Report Date:
date
C1302584 (UMLS CUI [1,1])
Item Group
FOLLOW-UP CONTACT (DAY 0)
CONTACT [CONTAC]
Item
Was the subject contacted 2-4 days after study treatment?
boolean
C1705415 (UMLS CUI [1,1])
C2709088 (UMLS CUI [1,2])
CONTACT_DT [CONDT]
Item
Date of Contact:
date
C1705415 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
ANTIBIOTICS_CURRENT [ABXCR]
Item
Has the subject been taking the prescribed self-administered post-injection antimicrobials?
boolean
C0338237 (UMLS CUI [1])
VISION_DECREASED [VSNDEC]
Item
Decrease in Vision: Has the subject experienced a decrease in vision in the study eye since treatment?
boolean
C4280600 (UMLS CUI [1])
EYE_PAIN [EYEPN]
Item
Eye Pain: Has the subject had any eye pain in the study eye since treatment?
boolean
C0151827 (UMLS CUI [1])
EYE_REDNESS [EYERED]
Item
Unusual Redness: Has the subject had any new or unusual redness in the study eye (other than localized redness at the injection site) since treatment?
boolean
C0235267 (UMLS CUI [1])
NEW_SYMPTOM [NEWSX]
Item
New Ocular Symptoms: Has the subject experienced any other new ocular symptoms in the study eye since treatment?
boolean
C0586406 (UMLS CUI [1])
ASSESSMENT_DONE [ASMTDN]
Item
Safety Assessment Visit: Was the subject asked to return to the clinic for a safety assessment visit?
boolean
C0589121 (UMLS CUI [1,1])
C0549076 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial